Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Gentiva® Health Services Reports Second Quarter 2013 Results


      News provided by

      Gentiva Health Services, Inc.

      Aug 01, 2013, 07:00 ET

      Share this article

      Share this article


      ATLANTA, Aug. 1, 2013 /PRNewswire/ -- Gentiva Health Services, Inc. (NASDAQ: GTIV), the largest provider of home health and hospice services in the United States based on revenue, today reported second quarter 2013 results.  Quarterly highlights include:

      • Net revenues of $414.4 million.
      • Adjusted income attributable to Gentiva shareholders per diluted share of $0.22.
      • Adjusted EBITDA of $39.0 million.
      • Free cash flow of $25.9 million.

      Second quarter 2013 financial highlights include: 

      • Net revenues of $414.4 million, a decrease of 3% compared to $427.7 million for the quarter ended June 30, 2012.  During the quarter ended June 30, 2013, net revenues were negatively impacted by the 2013 home health Medicare rate reduction, the full-quarter effect of the 2% sequestration rate cut on our Medicare-based revenues and the sale or closure of branches in the prior year. Excluding the impact of branches sold or closed, net revenues would have been down 2% compared to the second quarter of 2012.  Net revenues included home health episodic revenues of $206.7 million, flat compared to $207.5 million in the 2012 second quarter.  Hospice revenues were $179.2 million, a decrease of 7% compared to $192.0 million in the 2012 second quarter.  Hospice represented 43% of total net revenues in the second quarter of 2013, compared to 45% in the 2012 second quarter.
      • Income attributable to Gentiva shareholders of $6.3 million, or $0.20 per diluted share, compared to $13.9 million, or $0.46 per diluted share, for the second quarter of 2012.
      • Adjusted income attributable to Gentiva shareholders of $6.8 million, compared with $10.7 million in the comparable 2012 period. On a diluted per share basis, adjusted income attributable to Gentiva shareholders was $0.22 for the second quarter of 2013 as compared to $0.35 for the second quarter of 2012.
      • Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) was $39.0 million in the second quarter of 2013 as compared to $48.3 million in the second quarter of 2012.  Adjusted EBITDA as a percentage of net revenues was 9.4% in the second quarter of 2013 versus 11.3% in the prior year period.

      Adjusted income attributable to Gentiva shareholders and Adjusted EBITDA exclude charges related to restructuring, legal settlements, acquisition and integration activities and other special items.

      Highlights for the six months ended June 30, 2013 include: 

      • Net revenues of $830.0 million, a decrease of 4% as compared to $863.3 million for the prior year period. Net revenues included home health episodic revenues of $414.1 million, compared to $418.1 million in the comparable 2012 period.  Hospice revenues were $358.7 million, compared to $387.7 million in the comparable 2012 period. 
      • Loss attributable to Gentiva shareholders of $200.8 million, or $6.51 per diluted share.  Income attributable to Gentiva shareholders in the comparable 2012 period was $18.7 million, or $0.61 per diluted share.
      • Adjusted income attributable to Gentiva shareholders of $13.9 million, compared with $18.1 million in the 2012 period. On a diluted per share basis, adjusted income attributable to Gentiva shareholders was $0.45 as compared with $0.59 in the corresponding period of 2012, prior to the $0.03 add-back in the first quarter of 2012 for credit agreement amendment expenses.
      • Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) was $78.1 million as compared to $90.2 million in the 2012 period.  Adjusted EBITDA as a percentage of net revenues was 9.4% versus 10.5% in the prior-year period.  

      Cash Flow and Balance Sheet Highlights

      At June 30, 2013, the Company reported cash and cash equivalents of $185.1 million, up from $159.6 million at March 31, 2013.  Total outstanding debt was $910.2 million as of June 30, 2013.    Total Company days sales outstanding, or DSO, was 52 days at June 30, 2013, flat with the DSO at March 31, 2013.

      For the second quarter of 2013, net cash provided by operating activities was $30.7 million, compared to $83.8 million in the prior year period for 2012, which included a significant benefit from the reduction of  DSO.  Free cash flow was $25.9 million for the second quarter of 2013, compared to $80.7 million in the prior year period.  Free cash flow is calculated as net cash provided by operating activities less capital expenditures.

      Full-Year 2013 Outlook

      Based on first half 2013 results and the potential fourth quarter 2013 impact of the proposed 2014 Medicare home health and hospice reimbursement rules, the Company now expects full-year net revenues to be in the range of $1.67 billion to $1.70 billion.  The Company continues to expect 2013 adjusted income attributable to Gentiva shareholders to be in the range of $0.90 to $1.10 on a diluted per share basis.

      Non-GAAP Financial Measures

      The information provided in this press release includes certain non-GAAP financial measures as defined under SEC rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those historical measures to the most directly comparable GAAP measures.

      A reconciliation of adjusted income attributable to Gentiva shareholders to net income, the most directly comparable GAAP measure, is not accessible on a forward-looking basis without unreasonable effort due to the inherent difficulties in predicting the costs of restructuring, legal settlements and merger and acquisition activities and the impact of any future acquisitions or divestitures, which can fluctuate significantly and may have a significant impact on net income.

      Conference Call and Webcast Details

      The Company will comment further on its second quarter 2013 results during its conference call and live webcast to be held Thursday, August 1, 2013 at 9:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #17144988. The webcast is an audio-only, one-way event. Webcast listeners who wish to ask questions must participate in the conference call. Log onto http://investors.gentiva.com/events.cfm to hear the webcast. A replay of the call will be available on August 1 and will remain available continuously through August 8. To listen to a replay of the call from the United States, Canada or international locations dial (800) 585-8367 or (404) 537-3406 and enter the following PIN at the prompt: 17144988. Visit http://investors.gentiva.com/events.cfm to access the webcast archive. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call will be posted on the Company's website.

      About Gentiva Health Services, Inc.

      Gentiva Health Services, Inc. is the nation's largest provider of home health and hospice services based on revenue, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. GTIV-G

      (unaudited tables and notes follow)

      Gentiva Health Services, Inc. and Subsidiaries

      Condensed Consolidated Financial Statements and Supplemental Information

      (Unaudited)


















      (in 000's, except per share data)

      2nd Quarter


      Six Months




      2013


      2012


      2013


      2012

      Condensed Statements of Comprehensive Income (Loss)










      Net revenues

      $

      414,424


      $

      427,691


      $

      830,015


      $

      863,343



      Cost of services sold

      218,947


      222,737


      440,520


      455,598



      Gross profit

      195,477


      204,954


      389,495


      407,745



      Selling, general and administrative expenses

      (161,937)


      (163,928)


      (321,814)


      (337,635)



      Gain on sale of businesses

      —


      5,447


      —


      5,447



      Goodwill and other long-lived asset impairment

      —


      —


      (224,320)


      —



      Interest income

      642


      697


      1,427


      1,358



      Interest expense and other

      (22,790)


      (23,352)


      (45,868)


      (45,515)



      Income (loss) before income taxes

      11,392


      23,818


      (201,080)


      31,400



      Income tax (expense) benefit

      (4,829)


      (9,646)


      587


      (12,175)



      Net income (loss)

      6,563


      14,172


      (200,493)


      19,225



      Less: Net income attributable to noncontrolling interests

      (216)


      (263)


      (337)


      (476)



      Net income (loss) attributable to Gentiva shareholders

      $

      6,347


      $

      13,909


      $

      (200,830)


      $

      18,749













      Total comprehensive income (loss)

      $

      6,563


      $

      14,172


      $

      (200,493)


      $

      19,225












      Earnings per Share










      Net income (loss) attributable to Gentiva shareholders:










      Basic

      $

      0.21


      $

      0.46


      $

      (6.51)


      $

      0.61



      Diluted

      $

      0.20


      $

      0.46


      $

      (6.51)


      $

      0.61













      Weighted average shares outstanding:










      Basic

      30,941


      30,338


      30,863


      30,532



      Diluted

      31,239


      30,446


      30,863


      30,632

      (in 000's)







      Condensed Balance Sheets





      ASSETS

      Jun 30, 2013


      Dec 31, 2012



      Cash and cash equivalents

      $

      185,122


      $

      207,052



      Accounts receivable, net (A)

      252,589


      251,080



      Deferred tax assets

      9,051


      12,263



      Prepaid expenses and other current assets

      43,162


      45,632



      Total current assets

      489,924


      516,027









      Notes receivable from CareCentrix

      28,471


      28,471



      Fixed assets, net

      38,273


      41,414



      Intangible assets, net

      191,601


      193,613



      Goodwill

      435,747


      656,364



      Other assets

      72,208


      75,045



      Total assets

      $

      1,256,224


      $

      1,510,934








      LIABILITIES AND EQUITY






      Current portion of long-term debt

      $

      12,500


      $

      25,000



      Accounts payable

      12,706


      13,445



      Payroll and related taxes

      42,069


      45,357



      Deferred revenue

      38,063


      37,444



      Medicare liabilities

      16,035


      27,122



      Obligations under insurance programs

      57,546


      56,536



      Accrued nursing home costs

      19,866


      18,428



      Other accrued expenses

      50,296


      66,567



      Total current liabilities

      249,081


      289,899









      Long-term debt

      897,682


      910,182



      Deferred tax liabilities, net

      31,392


      42,165



      Other liabilities

      39,015


      33,988



      Total equity

      39,054


      234,700



      Total liabilities and equity

      $

      1,256,224


      $

      1,510,934









      Common shares outstanding

      31,315


      30,748







      (A) Accounts receivable, net included an allowance for doubtful accounts of $9.1 million and $8.8 million at June 30, 2013 and December 31, 2012, respectively.

      (in 000's)









      Six Months

      Condensed Statements of Cash Flows

      2013


      2012


      OPERATING ACTIVITIES:





      Net (loss) income

      $

      (200,493)


      $

      19,225


      Adjustments to reconcile net (loss) income to net cash provided
         by operating activities:






      Depreciation and amortization

      9,511


      14,722



      Amortization and write-off of debt issuance costs

      6,463


      7,020



      Provision for doubtful accounts

      2,680


      3,746



      Equity-based compensation expense

      3,969


      3,442



      Windfall tax benefits associated with equity-based compensation

      (82)


      —



      Gain on sale of businesses

      —


      (5,447)



      Goodwill and other long-lived asset impairment

      224,320


      —



      Deferred income tax (benefit) expense

      (7,983)


      9,906


      Changes in assets and liabilities, net of effects from acquisitions
         and dispositions:






      Accounts receivable

      (3,919)


      26,251



      Prepaid expenses and other current assets

      1,727


      (7,524)



      Current liabilities

      (27,705)


      (28,314)


      Other, net

      1,678


      6,117


      Net cash provided by operating activities

      10,166


      49,144








      INVESTING ACTIVITIES:





      Purchase of fixed assets

      (7,521)


      (6,941)


      Proceeds from sale of businesses, net of cash transferred

      508


      6,090


      Net cash used in investing activities

      (7,013)


      (851)








      FINANCING ACTIVITIES:





      Proceeds from issuance of common stock

      1,852


      1,640


      Windfall tax benefits associated with equity-based compensation

      82


      —


      Payment of contingent consideration accrued at acquisition date

      (1,500)


      —


      Repayment of long-term debt

      (25,000)


      (50,000)


      Repurchase of common stock

      —


      (4,974)


      Debt issuance costs

      —


      (4,125)


      Other

      (517)


      (468)


      Net cash used in financing activities

      (25,083)


      (57,927)








      Net change in cash and cash equivalents

      (21,930)


      (9,634)


      Cash and cash equivalents at beginning of period

      207,052


      164,912


      Cash and cash equivalents at end of period

      $

      185,122


      $

      155,278








      SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:











      Interest paid

      $

      39,069


      $

      38,402


      Income taxes paid

      $

      522


      $

      4,014










      Six Months

      A reconciliation of Free cash flow to Net cash provided by
         operating activities follows:

      2013


      2012



      Net cash provided by operating activities

      $

      10,166


      $

      49,144



      Less: Purchase of fixed assets

      (7,521)


      (6,941)



      Free cash flow

      $

      2,645


      $

      42,203









      (in 000's)












      Supplemental Information

      2nd Quarter


      Six Months




      2013


      2012


      2013


      2012

      Segment Information (2)













      Net revenues










      Home Health

      $

      235,216


      $

      235,687


      $

      471,277


      $

      475,651



      Hospice

      179,208


      192,004


      358,738


      387,692


      Total net revenues

      $

      414,424


      $

      427,691


      $

      830,015


      $

      863,343












      Operating contribution (4)










      Home Health

      $

      29,917


      $

      36,383


      $

      60,105


      $

      62,259



      Hospice

      26,437


      35,146


      53,858


      67,628


      Total operating contribution

      56,354


      71,529


      113,963


      129,887












      Corporate administrative expenses

      (18,084)


      (23,211)


      (36,771)


      (45,055)


      Goodwill and other long-lived asset impairment (5)

      —


      —


      (224,320)


      —


      Depreciation and amortization

      (4,730)


      (7,292)


      (9,511)


      (14,722)


      Gain on sale of businesses (6)

      —


      5,447


      —


      5,447


      Interest expense and other, net (7)

      (22,148)


      (22,655)


      (44,441)


      (44,157)


      Income (loss) before income taxes

      $

      11,392


      $

      23,818


      $

      (201,080)


      $

      31,400












      Home Health operating contribution margin %

      12.7%


      15.4%


      12.8%


      13.1%


      Hospice operating contribution margin %

      14.8%


      18.3%


      15.0%


      17.4%
























      2nd Quarter


      Six Months


      Net Revenues by Major Payer Source:

      2013


      2012


      2013


      2012



      Medicare










      Home Health

      $

      192,733


      $

      186,154


      $

      385,853


      $

      376,771



      Hospice

      167,788


      179,554


      335,061


      361,553



      Total Medicare

      360,521


      365,708


      720,914


      738,324



      Medicaid and local government

      18,664


      18,258


      36,934


      37,719



      Commercial insurance and other:










      Paid at episodic rates

      13,974


      21,313


      28,229


      41,287



      Other

      21,265


      22,412


      43,938


      46,013



      Total commercial insurance and other

      35,239


      43,725


      72,167


      87,300



      Total net revenues

      $

      414,424


      $

      427,691


      $

      830,015


      $

      863,343
























      2nd Quarter


      Six Months

      A reconciliation of Adjusted EBITDA to Net income (loss) attributable to Gentiva shareholders follows:

      2013


      2012


      2013


      2012


      Adjusted EBITDA (3)

      $

      39,014


      $

      48,343


      $

      78,077


      $

      90,248


      Cost savings, restructuring, legal settlement and acquisition and integration costs (4)

      (744)


      (25)


      (885)


      (5,416)


      Goodwill and other long-lived asset impairment (5)

      —


      —


      (224,320)


      —


      Gain on sale of businesses (6)

      —


      5,447


      —


      5,447


      EBITDA (4)

      38,270


      53,765


      (147,128)


      90,279


      Depreciation and amortization

      (4,730)


      (7,292)


      (9,511)


      (14,722)


      Interest expense and other, net (7)

      (22,148)


      (22,655)


      (44,441)


      (44,157)


      Income (loss) before income taxes

      11,392


      23,818


      (201,080)


      31,400


      Income tax (expense) benefit (8)

      (4,829)


      (9,646)


      587


      (12,175)


      Net income (loss)

      6,563


      14,172


      (200,493)


      19,225


      Less: Net income attributable to noncontrolling interests

      (216)


      (263)


      (337)


      (476)


      Net income (loss) attributable to Gentiva shareholders

      $

      6,347


      $

      13,909


      $

      (200,830)


      $

      18,749


      A reconciliation of Adjusted income attributable to Gentiva shareholders to Net income (loss) (all items presented are net of tax): (3)















      2nd Quarter


      Six Months


      2013


      2012


      2013


      2012









      Adjusted income attributable to Gentiva shareholders

      $

      6,799


      $

      10,695


      $

      13,906


      $

      18,140

      Cost savings, restructuring, legal settlement and acquisition and integration costs (4)

      (452)


      (34)


      (538)


      (3,215)

      Goodwill and other long-lived asset impairment (5)

      —


      —


      (214,198)


      —

      Gain on sale of businesses (6)

      —


      3,248


      —


      3,248

      Tax valuation allowance on OIG legal settlement

      —


      —


      —


      576

      Income (loss) attributable to Gentiva shareholders

      6,347


      13,909


      (200,830)


      18,749

      Add back: Net income attributable to noncontrolling interests

      216


      263


      337


      476

      Net income (loss)

      $

      6,563


      $

      14,172


      $

      (200,493)


      $

      19,225









      Adjusted income attributable to Gentiva shareholders per diluted share

      $

      0.22


      $

      0.35


      $

      0.45


      $

      0.59

      Cost savings, restructuring, legal settlement and acquisition and integration costs (4)

      (0.02)


      —


      (0.02)


      (0.11)

      Goodwill and other long-lived asset impairment (5)

      —


      —


      (6.94)


      —

      Gain on sale of businesses (6)

      —


      0.11


      —


      0.11

      Tax valuation allowance on OIG legal settlement

      —


      —


      —


      0.02

      Income (loss) attributable to Gentiva shareholders per diluted share

      0.20


      0.46


      (6.51)


      0.61

      Add back: Net income attributable to noncontrolling interests

      0.01


      0.01


      0.01


      0.02

      Net income (loss) per diluted share

      $

      0.21


      $

      0.47


      $

      (6.50)


      $

      0.63

















      Operating Metrics

      2nd Quarter


      Six Months


      2013


      2012


      2013


      2012

      Home Health








      Episodic admissions

      48,300


      48,800


      98,700


      100,200

      Total episodes

      71,000


      71,400


      143,200


      144,800

      Episodes per admission

      1.47


      1.46


      1.45


      1.44

      Revenue per episode

      $

      2,910


      $

      2,905


      $

      2,890


      $

      2,890









      Hospice








      Admissions

      12,100


      12,900


      25,700


      26,700

      Average daily census

      12,800


      13,700


      12,800


      13,700

      Patient days (in thousands)

      1,164


      1,243


      2,310


      2,499

      Revenue per patient day

      $

      154


      $

      154


      $

      155


      $

      155

      Length of stay at discharge (in days)

      97


      86


      98


      89

      Services by patient type:








      Routine

      98%


      98%


      98%


      98%

      General Inpatient & Other

      2%


      2%


      2%


      2%

       Notes:

      1. The comparability between reporting periods has been affected by the following items:

      a. The Company completed several acquisitions, closed a significant number of branch operations and sold a number of operating units affecting the reporting periods presented as follows:

        • During the second quarter of 2013, the Company completed the acquisition of Hope Hospice.
        • During the third quarter of 2012, the Company completed the acquisitions of Family Home Care, North Mississippi Hospice and Advocate Hospice.
        • During the fourth quarter of 2012, the Company sold its Phoenix area hospice operations.  During the second quarter of 2012, the Company sold eight home health branches and four hospice branches in Louisiana.

      During the first quarter of 2012, the Company continued a comprehensive review of its branch structure, support infrastructure and other significant expenditures in order to reduce its ongoing operating costs given the challenging rate environment facing the Company. As a result of this effort, the Company closed or divested 4 home health branches and completed significant reductions in staffing levels in regional, area and corporate support functions.

      As a result of this activity, the Company's revenue for the second quarter and first six months of 2013 were negatively impacted by approximately $5 million and $14 million, respectively, as compared to the second quarter and first six months of 2012.

      b. The first six months of 2013 included 181 days of activity as compared to 182 days for the first six months of 2012 due to 28 days in February 2013 versus 29 days in February 2012.   

      2. The Company's senior management evaluates performance and allocates resources based on operating contributions of the operating segments, which exclude corporate expenses, depreciation, amortization, and interest expense and other (net), but include revenues and all other costs directly attributable to the specific segment. 

      3. Adjusted EBITDA, a non-GAAP financial measure, is defined as income before interest expense and other (net of interest income), income taxes, depreciation and amortization and excluding charges relating to (i) cost savings and other restructuring, legal settlements, and acquisition and integration activities, (ii) gain on sale of businesses and (iii) goodwill and other long-lived asset impairment.  Management uses Adjusted EBITDA to evaluate overall performance and compare current operating results with other companies in the healthcare industry. Adjusted EBITDA should not be considered in isolation or as a substitute for income from continuing operations, net income, operating income or cash flow statement data determined in accordance with accounting principles generally accepted in the United States.  Because Adjusted EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States and is susceptible to varying calculations, it may not be comparable to similarly titled measures in other companies.

      Adjusted income attributable to Gentiva shareholders is defined as income attributable to Gentiva shareholders, excluding (i) tax reserves relating to the OIG settlement, (ii) gain on sale of businesses, (iii) charges relating to cost savings and other restructuring, legal settlements, and acquisition and integration activities and (iv) goodwill and other long-lived asset impairment. 

      4. Operating contribution and EBITDA included charges relating to cost savings and other restructuring, legal settlements and acquisition and integration activities of $0.8 million and $0.9 million for the second quarter and first six months of 2013, respectively. For the first six months of 2012, the Company recorded charges of $5.4 million.

      For both the second quarter and first six months of 2013, the Company recorded restructuring costs of $0.2 million. For the second quarter and first six months of 2013, acquisition and integration activities of $0.6 million and $0.7 million, respectively, primarily related to the Company's acquisition of Hope Hospice, Inc.

      For the first six months of 2012, the Company recorded (i) restructuring costs of $1.3 million and (ii) legal settlement reserves of $5.0 million, associated with the tentative settlement of the Wilkie wage and hour lawsuit, partially offset by a reduction in acquisition and integration costs of $0.9 million, primarily relating to favorable lease settlements associated with Odyssey HealthCare, Inc.

      These charges were reflected as follows for segment reporting purposes (dollars in millions):


      2nd Quarter


      Six Months


      2013


      2012


      2013


      2012













      Home Health

      $

      —


      $

      (0.1)


      $

      —


      $

      5.7

      Hospice

      0.7


      0.3


      0.7


      0.1

      Corporate expenses

      0.1


      (0.2)


      0.2


      (0.4)

      Total

      $

      0.8


      $

      —


      $

      0.9


      $

      5.4













      5. During the first six months of 2013, the Company recorded non-cash charges of $224.3 million related to goodwill and other long-lived assets.

      At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit due to lower than expected average daily census and higher than expected discharge rates during the quarter. Based on the results of the interim impairment test, the Company's Hospice reporting unit had an estimated fair value of approximately $555 million. As such the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million. As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million.

      In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.

      6. During the second quarter of 2012, the Company completed the sale of eight home health branches and four hospice branches in Louisiana, pursuant to an asset purchase agreement, for total consideration of approximately $6.4 million. 

      Effective May 31, 2012, the Company completed the sale of its Gentiva consulting business to MP Healthcare Partners, LLC pursuant to an asset purchase agreement, for cash consideration of approximately $0.3 million. In connection with the sales, the Company recorded a gain on sale of businesses of approximately $5.4 million for the second quarter and first six months of 2012.

      7. Interest expense and other, net for the first six months of 2012 included charges of approximately $0.5 million relating to the write-off of deferred debt issuance costs associated with Amendment No. 3 to the Company's credit agreement.

      8. The Company's effective tax rate was a tax provision of 42.4% and a tax benefit of 0.3% for the second quarter and first six months of 2013, respectively, as compared to a tax provision of 40.5% and 38.8% for the second quarter and first six months of 2012, respectively.

      During the first six months of 2013, the Company recorded non-cash impairment charges of $224.3 million related to goodwill and other long-lived assets (see note 5).  Excluding the impact of the impairment charges, the Company's effective tax rate would have been 40.6% for the first six months of 2013.

      During the first six months of 2012, the Company recorded a favorable tax reserve adjustment upon resolution of an uncertain tax position associated with the deductibility of a portion of the Company's settlement payment to the Office of the Inspector General.  Excluding the impact of the favorable tax reserve adjustment, the Company's effective tax rate would have been 40.8% for the first six months of 2012.

      Forward-Looking Statements

      Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; the impact on our Company of healthcare reform legislation and its implementation through governmental regulations; legislative proposals for healthcare reform; changes in Medicare, Medicaid and commercial payer reimbursement levels; the outcome of any inquiries into the Company's operations and business practices by governmental authorities; compliance with any corporate integrity agreement affecting the Company's operations; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; ability to access capital markets; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, terrorist acts or cyber-attacks; availability, effectiveness, stability and security of the Company's information technology systems; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; ability to maintain compliance with its financial covenants under the Company's credit agreement; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission, including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 31, 2012.

      Financial and Investor Contact:
      Eric Slusser
      770-951-6101
      eric.slusser@gentiva.com
      or
      John Mongelli
      770-951-6496
      john.mongelli@gentiva.com

      Media Contact:
      Scott Cianciulli
      Brainerd Communicators
      212-986-6667
      cianciulli@braincomm.com

      SOURCE Gentiva Health Services, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.